Literature DB >> 34278610

Sites of Cre-recombinase activity in mouse lines targeting skeletal cells.

Greig Couasnay1, Maria-Bernadette Madel1, Joohyun Lim2, Brendan Lee2, Florent Elefteriou1,2.   

Abstract

The Cre/Lox system is a powerful tool in the biologist's toolbox, allowing loss and gain-of-function studies, as well as lineage tracing, through gene recombination in a tissue-specific and inducible manner. Evidence indicates, however, that Cre transgenic lines have a far more nuanced and broader pattern of Cre activity than initially thought, exhibiting "off-target" activity in tissues/cells other than the ones they were originally designed to target. With the goal of facilitating the comparison and selection of optimal Cre lines to be used for the study of gene function, we have summarized in a single manuscript the major sites and timing of Cre activity of the main Cre lines available to target bone mesenchymal stem cells, chondrocytes, osteoblasts, osteocytes, tenocytes and osteoclasts, along with their reported sites of "off-target" Cre activity. We also discussed characteristics, advantage and limitations of these Cre lines for users to avoid common risks related to over- or misinterpretation based on the assumption of strict cell-type specificity or unaccounted effect of the Cre transgene or Cre inducers. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  Cre/lox; Osteoblast; Osteoclast; Osteocyte; Osteoprogenitor; Stromal/Stem Cells; Tenocyte; Transgenic

Year:  2021        PMID: 34278610     DOI: 10.1002/jbmr.4415

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  5 in total

Review 1.  Skeletal and gene-regulatory functions of nuclear sex steroid hormone receptors.

Authors:  Akira Hayakawa; Tomohiro Kurokawa; Yoshiaki Kanemoto; Takahiro Sawada; Jinichi Mori; Shigeaki Kato
Journal:  J Bone Miner Metab       Date:  2022-01-25       Impact factor: 2.626

2.  Sexually Dimorphic Increases in Bone Mass Following Tissue-specific Overexpression of Runx1 in Osteoclast Precursors.

Authors:  Martha Elena Díaz-Hernández; Christopher W Kinter; Shana R Watson; Giovanni Mella-Velazquez; Jarred Kaiser; Guanglu Liu; Nazir M Khan; Joseph L Roberts; Joseph Lorenzo; Hicham Drissi
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

3.  Ablation of the miRNA cluster 24 in cartilage and osteoblasts impairs bone remodeling.

Authors:  Veronika S Georgieva; Björn Bluhm; Kristina Probst; Mengjie Zhu; Juliane Heilig; Anja Niehoff; Bent Brachvogel
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

4.  Anxiety and Cognition in Cre- Collagen Type II Sirt1 K/O Male Mice.

Authors:  Biana Shtaif; Shay Henry Hornfeld; Michal Yackobovitch-Gavan; Moshe Phillip; Galia Gat-Yablonski
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-19       Impact factor: 5.555

5.  Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice.

Authors:  Zamzam Awida; Sahar Hiram-Bab; Almog Bachar; Hussam Saed; Dan Zyc; Anton Gorodov; Nathalie Ben-Califa; Sewar Omari; Jana Omar; Liana Younis; Jennifer Ana Iden; Liad Graniewitz Visacovsky; Ida Gluzman; Tamar Liron; Bitya Raphael-Mizrahi; Albert Kolomansky; Martina Rauner; Ben Wielockx; Yankel Gabet; Drorit Neumann
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.